Keywords: xenova, initiates, ph, iib, trial, ta-cd, uk
Xenova initiates Ph IIb trial of TA-CD
Article | 03 November 2003
UK biopharmaceutical company Xenova has initiated the first randomized,placebo-controlled Phase IIb clinical trial of TA-CD, its therapeutic vaccine under ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
